Clinical Trials Consulting & Training Lt - Accounts to registrar (filleted) - small 18.2

REGISTERED NUMBER: 06386114 (England and Wales)

Clinical Trials Consulting

& Training Limited

Unaudited Financial Statements for the Year Ended 31st March 2020

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Dr. S J Day

Mrs. N D M Day

SECRETARY:

Mrs. N D M Day

REGISTERED OFFICE:

53 Portway

North Marston

Buckingham

Buckinghamshire

MK18 3PL

REGISTERED NUMBER:

06386114 (England and Wales)

ACCOUNTANTS:

Courts Accountancy Services Ltd

Investment House

26 Celtic Court

Ballmoor

Buckingham

Buckinghamshire

MK18 1RQ

FIXED ASSETS

Tangible assets

4

1,990

2,755

CURRENT ASSETS

Debtors

5

30,667

139,231

Cash at bank

506,125

394,241

536,792

533,472

CREDITORS

Amounts falling due within one year

6

52,219

73,275

NET CURRENT ASSETS

484,573

460,197

TOTAL ASSETS LESS CURRENT LIABILITIES

486,563

462,952

CAPITAL AND RESERVES

Called up share capital

100

100

Retained earnings

486,463

462,852

SHAREHOLDERS' FUNDS

486,563

462,952

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st March 2020.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st March 2020 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 23rd July 2020 and were signed on its behalf by:

Dr. S J Day - Director

Mrs. N D M Day - Director

1.	STATUTORY INFORMATION

Clinical Trials Consulting & Training Limited is a private company, limited by shares , registered in

England and Wales. The company's registered number and registered office address can be found on

the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding

discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

25% on reducing balance

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income

Statement, except to the extent that it relates to items recognised in other comprehensive income

or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been

enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed

at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods

different from those in which they are recognised in financial statements. Deferred tax is measured

using tax rates and laws that have been enacted or substantively enacted by the year end and that

are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is

probable that they will be recovered against the reversal of deferred tax liabilities or other future

taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the

company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2019 - 2 ) .

4.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

At 1st April 2019

5,156

Disposals

(317

)

At 31st March 2020

4,839

DEPRECIATION

At 1st April 2019

2,401

Charge for year

664

Eliminated on disposal

(216

)

At 31st March 2020

2,849

NET BOOK VALUE

At 31st March 2020

1,990

At 31st March 2019

2,755

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.20

31.3.19

£

£

Trade debtors

30,667

90,281

Other debtors

-

48,950

30,667

139,231

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.20

31.3.19

£

£

Bank loans and overdrafts

-

15,491

Trade creditors

36

-

Taxation and social security

50,482

57,564

Other creditors

1,701

220

52,219

73,275

7.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31st March 2020

and 31st March 2019:

31.3.20

31.3.19

£

£

Dr. S J Day and Mrs. N D M Day

Balance outstanding at start of year

88,950

89,437

Amounts repaid

(90,000

)

(487

)

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

(1,050

)

88,950